Bumper Offer - Urjas oil Just @ Rs. 1
Torleva 250 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Epilepsy. Other than this, Torleva 250 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Torleva 250 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Torleva 250 Tablet are Fatigue, Headache, Drowsiness. Some other side effects of Torleva 250 Tablet have been listed ahead. Usually, these side effects of Torleva 250 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Torleva 250 Tablet has a Moderate effect for pregnant women and Mild effect on lactating mothers. Warnings related to Torleva 250 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Torleva 250 Tablet are listed in the contraindications section below.
Drug reaction of Torleva 250 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Torleva 250 Tablet is not safe while driving, and is not addiction.
Torleva 250 Tablet is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Torleva 250 Tablet is used -
Moderate
Mild
Common
Is the use of Torleva 250 Tablet safe for pregnant women?
Torleva may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Torleva again without your doctor's advice.
Is the use of Torleva 250 Tablet safe during breastfeeding?
Torleva has been seen to have minimal side effects on breastfeeding women.
What is the effect of Torleva 250 Tablet on the Kidneys?
Torleva rarely affects the kidneys.
What is the effect of Torleva 250 Tablet on the Liver?
Torleva has very mild side effects on the liver.
What is the effect of Torleva 250 Tablet on the Heart?
Torleva is completely safe for the heart.
Torleva 250 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Torleva 250 Tablet unless your doctor advises you to do so -
Is this Torleva 250 Tablet habit forming or addictive?
Forming a habit of Torleva 250 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Torleva 250 Tablet, you should not drive or work on any heavy machine, as Torleva 250 Tablet can make you drowsy.
Is it safe?
Yes, but take Torleva 250 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, taking Torleva 250 Tablet can treat mental disorders.
Interaction between Food and Torleva 250 Tablet
Taking Torleva 250 Tablet with food does not harm your health.
Interaction between Alcohol and Torleva 250 Tablet
Consuming Torleva 250 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
